
Migrab L 75mg/20mg Capsule SR
Marketer
Novalab Healthcare Pvt Ltd
Salt Composition
Levosulpiride (75mg) + Rabeprazole (20mg)
Overview Migrab L 75mg/20mg Capsule SR
Gastroesophageal reflux disease (GERD), peptic ulcers, and irritable bowel syndrome may be treated with the prescription medication Migrab L 75mg/20mg SR Capsules. This medication lessens excessive stomach acid production and hinders its backflow into the esophagus. Dosage and duration for Migrab L 75mg/20mg SR Capsules are determined by your physician and should be taken with or without food. Treatment duration depends on your response and condition; premature discontinuation can lead to symptom recurrence and worsening condition. Inform your doctor of all other medications you are using, as interactions are possible. Common, typically temporary, side effects include nausea, abdominal pain, diarrhea, gas, constipation, headache, fatigue, and flu-like symptoms. Report any concerns immediately to your doctor. Drowsiness and dizziness are possible; avoid driving or activities requiring alertness until the effects are known. Alcohol should be avoided due to potential increased drowsiness. A high-fiber diet, avoidance of trigger foods, increased hydration, and regular exercise can enhance treatment outcomes. Disclose any liver or kidney conditions, pregnancy, pregnancy plans, or breastfeeding to your doctor before commencing treatment.
Uses of Migrab L 75mg/20mg Capsule SR
Managing gastroesophageal reflux disease (GERD) | Treating peptic ulcers | Managing irritable bowel syndrome (IBS)
Major Benefits of Migrab L 75mg/20mg Capsule SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment period. Ingest the capsule whole; avoid chewing, crushing, or breaking it. Administer Migrab L 75mg/20mg sustained-release capsules on an empty stomach.
Common Side effects of Migrab L 75mg/20mg Capsule SR:
- Nausea
- Stomach pain
- Diarrhea
- Flatulence
- Constipation
- Headache
- Dizziness
- Weakness
- Sleepiness
- Flu-like symptoms
How to use Migrab L 75mg/20mg Capsule SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Migrab L 75mg/20mg SR Capsules. Ingest the capsule whole; do not crush, chew, or break it. Administer on an empty stomach.
How Migrab L 75mg/20mg Capsule SR works:
Each Migrab L 75mg/20mg sustained-release capsule contains levosulpiride and rabeprazole, a dual-action medication.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of alcohol and Migrab L 75mg/20mg SR capsules is contraindicated.
PregnancyCONSULT YOUR DOCTOR
The use of Migrab L 75mg/20mg SR Capsules during pregnancy may pose risks. While human data is scarce, animal studies indicate potential harm to the fetus. A physician will assess the potential benefits against any risks prior to prescribing this medication. Always seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Data on the use of Migrab L 75mg/20mg sustained-release capsules while breastfeeding is lacking. Seek medical advice from your physician.
DrivingUNSAFE
Driving ability may be impaired by side effects associated with Migrab L 75mg/20mg SR Capsules.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding Migrab L 75mg/20mg Capsule SR use in individuals with renal impairment. Physician consultation is advised. Preliminary findings, however, indicate that this medication should be administered to such patients with caution.
LiverCAUTION
For individuals with severe hepatic impairment, the use of Migrab L 75mg/20mg sustained-release capsules requires careful monitoring. Dosage modification of Migrab L 75mg/20mg sustained-release capsules may be necessary. Physician consultation is advised.
What if you forget to take Migrab L 75mg/20mg Capsule SR :
Should you forget a Migrab L 75mg/20mg Capsule SR dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual medication routine. Avoid taking a double dose.
Facts to Know About Migrab L 75mg/20mg Capsule SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Gastrointestinal system |
